Pharma Latch offers a range of intradermal injection devices based on a core platform technology
Our core technology utilises an array of opposing angled microneedles that latch into the skin at a preset depth, ensuring robust skin attachment and consistent needle-depth penetration.
The advantages of our platform include:
Pharma Latch Product Migration Pathway
Pharma Latch is unique in that we are a true platform technology. Our Pharma Latch Hollow and Self-injector device, contain the exact same microneedle array and insertion mechanism, allowing for seamless product transition.
We have also developed a solid-coated Micro-array Patch (MAP) that utilises the same Latch technology.